Lit Cardiovascular Flashcards
(180 cards)
What was the difference between the PetMAP vs HDO devices when measuring systolic BP in dogs?
Lyberg JVIM 2021
Mean SBP with petMAP was 14mm Hg higher vs HDO, and the difference between devices increased with increasing SBP. Underscore the need for validation of BP devices used clinically.
What was the diagnostic utility of a point-of-care NT-proBNP ELISA assay in clinically healthy cats in GP?
Lu JVIM 2021
Overall 43% sens, 96% spec in differentiating abnormal cats –> low sens indicates not effective as screening test, but positive result likely indicates cardiac dz & should FU with echo. Improved sens (71%) while maintaining similar spec (92%) if test is performed on cats with heart murmur.
What was the diagnostic utility of modified-vertebral left atrial size (M-VLAS) in determining left atrial enlargement in dogs with MMVD and comparison to an existing method?
Lam JVIM 2021
M-VLAS = series of measurements based on VHS, VLAS & RLAD (LA dimension). Cut-off value of ≥3.4 vertebrae using M-VLAS had 92.7% sens & 93.1% spec in predicting LA enlargement.
M-VLAS is superior to VHS – offers an accurate and repeatable way to radiographically identify LA enlargement (LA:Ao >/= 1.6) in dogs with MMVD.
a) Define left ventricular-arterial coupling (VAC) and b) its utility in the diagnosis and prognostication of dogs with MMVD.
Osuga JVIM 2021 (2 papers)
a) VAC is derived from estimate Ea (effective arterial elastance) to Ees (LV end-systolic elastance) ratio (Ea/Ees) by echo.
*Ea reflects arterial load of LV, Ees reflects LV systolic function.
b) Ea/Ees ratio was higher in stage C > B2 > B1 MMVD vs healthy dogs. Inappropriate VAC is associated with advanced disease severity in MMVD dogs.
Dogs with Ea/Ees >0.34 had poorer prognosis (50% shorter survival - MST 527d) vs dogs with Ea/Ees ≤0.34 (MST >1112d).
What was the correlation of serum Cl- at admission in dogs & cats with acute heart failure and the following:
a) Diuretic (frusemide) dose
b) Duration of hospitalisation
c) Survival time
Roche-Catholy JVIM 2021
a) Dogs only - neg correlation (worse hypoCl –> higher diuretic doses) may be useful as a marker of disease severity & therapeutic response in CHF dogs.
b) No sig correlation
c) No sig correlation
What were the effects of pimobendan in the outcome of cats with HCM and controlled CHF with/without LVOTO?
Schober JVIM 2021
No sig diff in outcome between treatment groups (pimo vs placebo).
Overall no identified benefit of pimobendan on 180d outcome (w/o needing furosemide dose escalation or death).
NB: Pimo did not induce/worsen LVOTO in HCM cats based on mean systolic PG measurements. PG across LVOT did increase post-pimo but cats were not clinical (weakness, severe hypotension, syncope, death). In fact, cats receiving chronic pimo tx had decreased LVOTO severity –> debunks concerns about long-term detrimental effects of pimo worsening LVOTO.
The prevalence of atrial fibrillation in MMVD dogs was ……%.
Risk factors for AFib development include ….(signalment), ….. stage MMVD. Associated echo parameters included decreased…., increased ….. and presence of ……
Guglielmini JVIM 2021
2.7%, mixed breed, male, advanced, fractional shortening, left atrial & ventricular dimension, pulmonary hypertension.
What was the effect of correcting serum [Cl-] in dogs with Stage C-D CHF?
Adin JVIM 2021
Serum [Cl−] increased after mathematical correction in Stage D CHF dogs but not in Stage C and non-CHF dogs. Although c[Cl−] was higher than m[Cl−] in Stage D dogs supportive of relative water excess, hypochloremia persisted, consistent with concurrent loop diuretic effects on electrolytes.
Serum chloride concentration useful in defining all stages of heart disease in dogs (true/false).
Adin JVIM 2021
True. Serum [Cl-] was the best differentiator of HD stage, a useful marker for stage D dogs.
What were the effects of pimobendan on left atrial function in cats with HCM?
Kochie JVIM 2021
Mild positive effect. Echo parameters – increased peak velocity of left auricular appendage flow, max LA volume, LA total emptying volume, peak velocity of late diastolic transmitral flow (A peak velocity), A velocity time integral.
What were the effects of diet change following a diagnosis of DCM in dogs?
Freid JVIM 2021
Overall improvement in cardiac function – decreased LVIDs & LA:Ao, longer survival (337d vs 215d with no diet change).
Which breed had LV M-mode prediction intervals that deviated from the population of dogs analysed?
Esser JVIM 2021
Newfoundland
*Sighthounds had increased cardiac dimensions (except Irish Wolfhound)
Which echo parameters were useful in predicting the first onset of AFib in dogs with MMVD?
Baron Toaldo JVIM 2021
Standard echo measurements – LA diameter, LVIDd
LA speckle tracing echo (STE) variables – peak atrial longitudinal strain (PALS) (represents the peak strain value during LV contraction)
How did torsemide compare to furosemide as 1st-line PO treatment for dogs with CHF associated with degenerative mitral valve disease, in terms of:
a) Treatment efficacy
b) Clinical response
c) Time to cardiac-related death
Besche JVIM 2020
a) TOR was non-inferior to FURO wrt achieving efficacy criterion by D14 (decreased pulmonary oedema & cough, no worsening of dyspnea or exercise tolerance).
b) Similar clinical response at D84 (74% dogs achieved with either TOR or FURO).
c) TOR significantly decreased risk of cardiac-related death (increased time to death or euthanasia).
What were the cardiovascular effects of oral steroid administration (2mg/kg/d) in healthy cats? (List 2 with significant changes & 1 without)
Block JVIM 2020
- Increased heart size (LA & LVID)
- Increased % change in individual NT-proBNP (>60% increase in 60% cats)
Overall suggests plasma volume expansion.
- No significant changes in BP.
Suspected findings are due to mineralocorticoid induced Na & H2O retention, due to BG remaining stable, as was BP.
What were the 2 major characteristics associated with plasma NT-proBNP concentration in cats?
What were the diagnostic test sensitivities & specificities for the NT-proBNP POC test & ELISA?
Hanås JVIM 2020
Male & HCM cats - higher NT-proBNP concentrations.
ELISA & POCT had similar sens & spec for detecting all 3 groups (HCM, HCM+LAE, HCM-LAE). Spec 97-98% for all groups. Sens - HCM cats 72-74%, HCM+LAE 100%, HCM-LAE 69% (note significant drop in the absence of LAE in HCM cats).
1) What were the 2 major characteristics associated with plasma NT-proBNP concentration in cats?
2) What were the diagnostic test sensitivities & specificities for the NT-proBNP POC test & ELISA in distinguishing HCM from healthy cats, with/without LA enlargement?
Hanås JVIM 2020
1) Male & HCM cats - higher NT-proBNP concentrations.
2) Overall both assays had similar sens & spec.
- HCM cats (sens 72-74%, spec 97- 98%)
- HCM+LAE (sens 100%, spec 97-98%)
- HCM-LAE (sens 69%, spec 97-98%).
*Overall good spec in all groups (true positives), but sens drops significantly in the absence of LA enlargement in HCM cats.
1) What were the main risk factors for development of transient myocardial thickening (TMT) in cats vs persistent HCM?
2) What was the outcome & prognosis of cats with CHF associated with TMT? And in comparison with CHF-HCM cats?
Novo Matos JVIM 2018
1) TMT - younger cats (2yo), antecedent events (recent GA»_space; trauma, +/- drugs or other systemic illness)
2) Maximal LV wall thickness & LA:Ao ratio decreased in 3.3 months.
Overall prognosis better in cats with TMT-CHF cf HCM-CHF. Reduction in LA/Ao over ~3 months.
100% survival in TMT cats, 56% HCM cats. Rare for CHF recurrence (5% TMT vs 71% HCM), most cases (95%) tx discontinued.
a) What characteristics were cats with HCM & outflow tract obstruction (OTO) more likely to have compared to cats without OTO?
b) What was the safety & efficacy of pimobendan in these 2 cat populations?
Ward JVIM 2020
a) OTO cats - younger, more likely cardiac murmur, more likely to manifest CHF as pulmonary oedema, less likely pleural effusion.
b) Overall well tolerated drug, SE in 4.6% cats (5.4% non-OTO cats 2% OTO cats). Most common GIT,lethargy, weakness. Drug stopped in 1.5% cats due to AE.
- Which 4 major echocardiographic variables affecting the right heart were noted in dogs with pulmonary hypertension (PHT)?
- Name 3 R-cardiac echo variables which were negative prognostic factors in relation to survival time in dogs with PHT.
Visser JVIM 2020
- RA enlargement 88%, RV enlargement 69%, PA enlargement 72%, decreased RV function (decr TAPSE) 33% dogs.
- Increased RA area, decreased RV function (TAPSE < 3.23mm/kg0.284) & R heart failure.
1) When comparing diagnostic performance, the VHS+VLAS had better ability to predict echocardiographic L heart enlargement (LHE) in preclinical MMVD dogs compared to VHS and VLAS alone. (T/F)
2) VHS ….. excluded pre-clinical MMVD dogs with LHE (sens…., spec….), while VHS …… (sens…., spec…) identified MMVD dogs with LHE.
Poad JVIM 2020
1) False - no diff, all moderate ability.
2) </=10.8, 91.1%, 69.4%. >11.7, 32.4%, 97.2%
There was a positive association between LA enlargement & cardiomegaly & bronchial narrowing in coughing dogs with cardiac murmurs. (T/F)
Lebastard JVIM 2021
True. Association supports heart size-associated exacerbation of cough in dogs with murmurs.
(2 papers)
The Amplatzer vascular plug II (AVP-II) device was safe & effective for closure of …. PDAs, with a closure rate of …..%, most of which occurred after …….
What is the advantage of using the Amplatzer Vascular Plug 4 to correct L-R PDA in small dogs? Was this effective?
Hildebrandt JVIM 2021
Moderate-large, 100%, 24hrs (1 dog had delayed complete closure after 3mths).
Hulsman JVIM 2020
(2 papers)
AVP-4 is the only self-expandable nitinol mesh occlusion device
which can be implanted through a 4Fr diagnostic catheter, so it is small enough to fit through the femoral artery diameter.
Yes, effective & technically easy. 5/7 dogs had immediate shunt closure, 1 dog with slightly undersized device had delayed closure after 2hrs, 1 dog with severely undersized AVP-4 had device embolised in the PA & required coil placement instead.
In dogs & cats with bidirectional and continuous right-to-left (reverse) PDA, list:
1) Clinical signs (including most common)
2) Prognosis (median survival time, negative or positive prognostic factors)
Greet JVIM 2021
1) Variable CSx:
Dogs - HL collapse most common. Exercise intolerance, signs of neuro disease, signs of GI dz, syncope, cough
Cats - variable.
Both - abdo distension, tachypnea/ dyspnea, asymptomatic.
2) MST 626d in dogs (range 1-3628d).
- Negative px: dogs with R-CHF at presentation (MST 58d vs 1839d).
- Positive px: dogs tx with sildanefil at presentation (MST 1839d vs 302d).